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Introduction
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections are major public health problems worldwide. It is estimated that over 350 million people are chronically infected with HBV [1] , more than 185 million with HCV [2] and over 35 million with HIV [3] . The greatest burden of disease is in low and middle income countries. These viruses singly or as coinfections can induce hepatic inflammation which potentially results in progressive fibrosis leading to cirrhosis and hepatocellular carcinoma. Haemodialysis (HD) patients are potentially susceptible to infection with these blood borne viral agents (HBV, HCV, HIV) compared to the general population making them a persistent public health concern as they are a cause of increased morbidity and mortality [4, 5] . The prevalence of HBV in dialysis facilities in Western Europe, United States of America and Japan has been shown to range between 0-6.6% [6, 7] . By contrast in Asia Pacific it ranged from 1.3 to 14.6% [8] . The prevalence of HCV in HD varies greatly ranging from a low 1% to as high as 70% being generally below 5% in high income countries [9] .
The major reasons for this high prevalence of infection with HCV and HBV in HD patients are; high prevalence of infection in the general population, lack of standard methods of prevention and effective vaccination, inadequate disinfection of dialysis machines and other medical equipment as well as the spread of infection from one patient to another [5] . In Cameroon, with a population of over 24 million inhabitants [10] , there were only two HD centres located in tertiary hospitals in the two largest cities, Yaoundé and Douala.
To address the growing demand for management of End stage Kidney Disease (ESKD), HD services were progressively decentralised from 2009 to second level regional hospitals. There are now a total of seven centres. In the Douala HD centre, the largest and busiest in Cameroon, the prevalence of HBV and HIV in 166 HD patients was 7.8% and 10.8% respectively [11] . However, in this same centre and at around the same time frame, baseline prevalence of HBV, HCV and HIV in ESKD patients prior to commencing HD was 6.2%, 20.6% and 9.3% respectively [12] .
Focus on the prevalence of blood borne viruses in HD centres and the determination of their risk factors will enable health planners in Cameroon to operate more effectively, to reduce disease prevalence and ultimately reduce rates of morbidity and mortality. Initial and regular evaluation may play an important role especially in the new centres which have limited experience with HD. The aim of this study was to determine the prevalence and factors associated with HBsAg, anti-HCV and HIV antibodies among HD patients in two newly created HD centers in Cameroon. 
Methods

Results
We included 104 participants in this study (44 in Buea and 60 in Bamenda) and their mean age was 48 (sd: 16) years. Table   1  The association between HIV positivity and STI as shown in this study could be a reflection of the latter as a risk factor for acquiring HIV.
Eloumou: study design, review of data and revision of manuscript. 
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